# Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

> **NCT06759155** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Vermont Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- OPSCC
- Oropharyngeal Squamous Cell Carcinoma (SCC)
- HPV Associated Cancers

## Interventions

- **RADIATION:** de-intensified radiation

## Key facts

- **NCT ID:** NCT06759155
- **Lead sponsor:** University of Vermont Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06759155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06759155, "Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06759155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*